4-Piperidinecarboxylic acid, 1-[3-chloro-5-[[[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]amino]carbonyl]-2-pyridinyl]-, ethyl ester

Avatrombopag Impurity 22 with CAS number 570403-14-4 is a pharmaceutical impurity reference standard used in quality control and analytical testing of Avatrombopag drug substances and formulations. This compound is categorized as a pharmaceutical impurity and is essential for regulatory compliance in drug manufacturing. The molecular formula is C31H38Cl2N6O3S2 with a molecular weight of 677.71 g/mol. The compound has a predicted density of 1.375+/-0.06 g/cm3 and a pKa value of 3.04+/-0.70. This impurity is related to Avatrombopag, a thrombopoietin receptor agonist developed by Lundbeck and AkaRx and approved for the treatment of thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. It is also used for treating immune thrombocytopenia. The compound has various synonyms including Avatrapa impurity 5, Avatrombopag Impurity 15, Avibactam impurity 04K-Z3, Avatroposide impurities21, and several complex chemical names describing its structure. This product is intended for non-medical purposes such as industrial applications or scientific research only. It cannot be used for clinical diagnosis or treatment of humans or animals. Pricing is available from multiple suppliers with minimum orders typically starting at 0.1KG and purity levels above 98-99%.